prognosis (n=48)
The cardioprotection by GLP-1 includes improvement in coronary blood flow [142, 143], decreases in cardiomyocyte apoptosis [144], and reduction in infarct size [97, 145]
BPC-157, or Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protein in gastric juice
Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y et al (2020) Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance
Compounded options through TrimRx dont depend on insurance approval
Concerns have arisen regarding compounded versions of GLP-1 drugs, with the FDA receiving over 700 adverse event reports due to dosing errors or unapproved formulations